# Adrenomedullin-RAMP2 Enhances Lung Endothelial Cell Homeostasis Under Shear Stress

**Authors:** Yongdae Yoon, Sean R. Duffy, Shannon E. Kirk, Kamoltip Promnares, Pratap Karki, Anna A. Birukova, Konstantin G. Birukov, Yifan Yuan

PMC · DOI: 10.3390/cells15020152 · Cells · 2026-01-14

## TL;DR

The study identifies adrenomedullin interacting with RAMP2 as a key pathway that improves lung endothelial cell stability and function under stress.

## Contribution

The novel finding is that ADM/RAMP2 signaling enhances endothelial homeostasis and barrier integrity under shear stress in engineered vascular models.

## Key findings

- Adrenomedullin (ADM) improves endothelial barrier integrity and anti-inflammatory responses in human pulmonary endothelial cells.
- ADM treatment maintains endothelial homeostasis markers under shear stress and enhances anti-coagulation by modulating THBD and F3.
- The ADM effect is mediated through RAMP2, as blocking RAMP2 attenuates these benefits.

## Abstract

Analysis of pulmonary vascular dysfunction in various lung pathologies remains challenging due to the lack of functional ex vivo models. Paracrine signaling in the lung plays a critical role in regulating endothelial maturation and vascular homeostasis. Previously, we employed single-cell RNA-sequencing (scRNAseq) to systematically map ligand–receptor (L/R) interactions within the lung vascular niche. However, the functional impact of these ligands on endothelial biology remained unknown. Here, we systematically evaluated selected ligands in vitro to assess their effects on endothelial barrier integrity, anti-inflammatory responses, and phenotypic maturation. Among the top soluble ligands, we found that adrenomedulin (ADM) exhibited superior barrier enhancing effect on human pulmonary endothelial cell monolayers, as evidenced by electrical cell impedance sensing (ECIS) and XperT assays. ADM also exhibited anti-inflammatory properties, decreasing ICAM1 and increasing IkBa expression in a dose-dependent manner. Perfusion is commonly used in bioengineered vascular model systems. Shear stress (15 dynes/cm2) alone increased endothelial characteristics, including homeostatic markers such as CDH5, NOS3, TEK, and S1PR1. ADM treatment maintained the enhanced level of these markers under shear stress and further improved anti-coagulation by increasing THBD and decreasing F3 expression and synergistically enhanced the expression of the native lung aerocyte capillary endothelial marker EDNRB. This effect was completely attenuated by a blockade of ADM receptor, RAMP2. Together, these findings identify ADM/RAMP2 signaling as a key paracrine pathway that enhances vascular barrier integrity, anti-inflammatory phenotype, and endothelial homeostasis, providing a framework for improving the physiological relevance of engineered vascular models.

## Linked entities

- **Genes:** ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383], NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792], CDH5 (cadherin 5) [NCBI Gene 1003], NOS3 (nitric oxide synthase 3) [NCBI Gene 4846], TEK (TEK receptor tyrosine kinase) [NCBI Gene 7010], S1PR1 (sphingosine-1-phosphate receptor 1) [NCBI Gene 1901], THBD (thrombomodulin) [NCBI Gene 7056], F3 (coagulation factor III, tissue factor) [NCBI Gene 2152], EDNRB (endothelin receptor type B) [NCBI Gene 1910], RAMP2 (receptor activity modifying protein 2) [NCBI Gene 10266]
- **Proteins:** ADM (adrenomedullin), RAMP2 (receptor activity modifying protein 2)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** S1PR1 (sphingosine-1-phosphate receptor 1) [NCBI Gene 1901] {aka CD363, CHEDG1, D1S3362, ECGF1, EDG-1, EDG1}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, TEK (TEK receptor tyrosine kinase) [NCBI Gene 7010] {aka CD202B, GLC3E, TIE-2, TIE2, VMCM, VMCM1}, EDNRB (endothelin receptor type B) [NCBI Gene 1910] {aka ABCDS, ET-B, ET-BR, ETB, ETB1, ETBR}, ADM (adrenomedullin) [NCBI Gene 133] {aka AM, PAMP}, CDH5 (cadherin 5) [NCBI Gene 1003] {aka 7B4, CD144}, RAMP2 (receptor activity modifying protein 2) [NCBI Gene 10266], THBD (thrombomodulin) [NCBI Gene 7056] {aka AHUS6, BDCA-3, BDCA3, CD141, THPH12, THRM}
- **Diseases:** Lung (MESH:D008171), inflammatory (MESH:D007249), pulmonary vascular dysfunction (MESH:D002561)
- **Chemicals:** XperT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12839701/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12839701/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12839701/full.md

---
Source: https://tomesphere.com/paper/PMC12839701